Explore
Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Read More
Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Read More
Trendline
Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference
Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference
Read More
Trendline
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Read More
Trendline
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments
Read More
Trendline
ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury
ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury
Read More
Trendline
Allucent Expands Leadership to Enhance Drug Development for Biopharma
Allucent Expands Leadership to Enhance Drug Development for Biopharma
Read More
Trendline
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
Read More
Trendline
Apnimed Secures $150 Million Financing for Sleep Apnea Drug Development
Apnimed Secures $150 Million Financing for Sleep Apnea Drug Development
Read More
Trendline
Amphastar Pharmaceuticals to Present at Needham Healthcare Conference Highlighting Strategic Growth
Amphastar Pharmaceuticals to Present at Needham Healthcare Conference Highlighting Strategic Growth
Read More
Trendline
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights
Read More
Trendline
Takeda Ends Partnership with Denali, Returns Dementia Drug Rights
Takeda Ends Partnership with Denali, Returns Dementia Drug Rights
Read More